1. Exposure–Response Relationship of T‐DM1: Insight Into Dose Optimization for Patients With HER2‐Positive Metastatic Breast Cancer. Issue 5 (31st January 2014) Authors: Wang, J; Song, P; Schrieber, S; Liu, Q; Xu, Q; Blumenthal, G; Amiri Kordestani, L; Cortazar, P; Ibrahim, A; Justice, R; Wang, Y; Tang, S; Booth, B; Mehrotra, N; Rahman, A Journal: Clinical pharmacology & therapeutics Issue: Volume 95:Issue 5(2014) Page Start: 558 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Toward greater insights on pharmacokinetics and exposure–response relationships for therapeutic biologics in oncology drug development. Issue 5 (15th March 2017) Authors: Wang, Y; Booth, B; Rahman, A; Kim, G; Huang, SM; Zineh, I Journal: Clinical pharmacology & therapeutics Issue: Volume 101:Issue 5(2017) Page Start: 582 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗